Atlas Trials

Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence

Clinical trial NCT05806164 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05806164
Sponsor
Women and Infants Hospital of Rhode Island
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Urgency Urinary Incontinence
Start date
2023-06-06
Primary completion
2026-08-30
Enrollment
432

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.